Boston Scientific cyberattack disrupts order processing and shipping globally

Boston Scientific on Wednesday disclosed a cyberattack that has affected the company’s ability to process and ship customers’ orders.

The medical device maker was hit by an attack that affected certain information technology systems, resulting in a global disruption to its operations, according to a filing with the Securities and Exchange Commission. Boston Scientific identified the attack on Tuesday.

Operational Impact

The attack has caused disruptions to the company’s information systems and business applications that support operations, including the ability to process and ship orders. The disruption is expected to continue, though Boston Scientific did not disclose for how long.

“While the Company is working diligently to restore affected functions and systems access, the timeline for a full restoration is not yet known,” Boston Scientific said in the filing.

In a statement posted to its website on Wednesday, the company said the attack resulted in a network outage, along with a disruption to its operations.

Financial and Market Impact

Boston Scientific has not yet determined whether the incident will have a material impact.

The company’s shares dropped by nearly 6% to $47.09 in premarket trading, and were down by more than 4% after the market opened.

Industry Context

Boston Scientific is the latest in what is becoming a long list of medical device companies to have reported a cyberattack in recent months, including Medtronic, Abbott, and Intuitive.

While most companies have not reported any impact on operations, Stryker suffered an attack in March that affected its ordering and shipping operations, much like Boston Scientific. Stryker’s cyberattack shut down the company’s ordering, shipping, and manufacturing capabilities for weeks and cut into its first-quarter results. The company is still recovering from the effects of the attack.

Analyst Commentary

Stifel analysts said there is little clarity in the filing on the exact impact to operations and the company’s guidance or outlook. However, the cyberattack does add uncertainty into what has already been a challenging year for the firm.

“From our perspective, it is still too early to know how Boston will approach communicating these issues and incorporating any potential impact,” the analysts wrote. “But, we must acknowledge that there is now increased uncertainty regarding our 2026 revenue, margin, and [earnings per share] outlook.”

Response and Investigation

Upon detection of the attack, Boston Scientific activated its response protocols and began an investigation with third-party cybersecurity experts to assess and contain the threat.

“The Company’s investigation of the cybersecurity incident is ongoing, and the full scope, nature and impacts, including operational and financial impacts, of the incident are not yet known,” Boston Scientific said in the filing.